Purple Biotech (PPBT) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PPBT Purple Biotech

Watchlist

5.420
+0.250+4.84%

Close Sep 27 16:00 ET

8.49MMarket Cap-423P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

H.C. Wainwright Maintains Purple Biotech(PPBT.US) With Buy Rating, Cuts Target Price to $33
Moomoo NewsSep 19 06:31 ET · Ratings
Express News | HC Wainwright & Co. Maintains Buy on Purple Biotech, Lowers Price Target to $8
BenzingaSep 19 06:29 ET
Purple Biotech Reveals Optimistic Cancer Treatment Data
TipRanksSep 18 06:57 ET
Purple Biotech Reported New Biomarker Findings From Phase 2 Study Of Its Lead Oncology Therapeutic Candidate CM24 In Combination With Bristol Myers Squibb's Nivolumab Plus Standard Of Care Chemotherapy
BenzingaSep 18 06:38 ET
Express News | Purple Biotech Reports Additional Positive Interim Data From Its Randomized Phase 2 Study With Its Lead Oncology Therapeutic Candidate Cm24
ReutersSep 18 06:30 ET
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
BenzingaSep 16 19:50 ET

Comments

Stock_Drift

Sep 18 05:47

$Purple Biotech (PPBT.US)$

Trytosaveabit

Sep 18 05:32

Update

$Purple Biotech (PPBT.US)$ Reuters· just
Purple Biotech Reports Additional Positive Interim Data From Its Randomized Phase 2 Study With Its Lead Oncology Therapeutic Candidate Cm24

Jaguar8

Sep 10 06:56

NEWS

$Purple Biotech (PPBT.US)$
Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research
REHOVOT, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced it has been selected for a poster presentation at the American Associati...